Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsTOPICALGeneric

CORDRAN N

FLURANDRENOLIDE; NEOMYCIN SULFATE

Standard Dose
0.05%;EQ 3.5MG BASE/GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview CORDRAN N is listed in Drugs@FDA under application 050345 (NDA).
  • Marketing status: Discontinued Active ingredient FLURANDRENOLIDE; NEOMYCIN SULFATE Form and strength OINTMENT;TOPICAL - 0.05%;EQ 3.5MG BASE/GM Sponsor LILLY Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview CORDRAN N is listed in Drugs@FDA under application 050345 (NDA). Marketing status: Discontinued Active ingredient FLURANDRENOLIDE; NEOMYCIN SULFATE Form and strength OINTMENT;TOPICAL - 0.05%;EQ 3.5MG BASE/GM Sponsor LILLY Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.